• Skip to primary navigation
  • Skip to main content

IMMUNOLOGY2024™

May 3–7, 2024 | Chicago, Illinois

  • Policies
  • Program
    • President’s Program
    • Distinguished Lectures
    • Major Symposia
    • Special Session
    • Committee Sponsored Sessions
    • Block Symposia
    • Poster Sessions
    • Award Presentations & Lectures
    • Career Development Sessions
    • Guest Sessions
    • AAI Business Meeting
    • Exhibitor Workshops
    • Social Events
  • Register
    • Registration FAQ
  • Hotels
  • Awards
  • Careers
    • For Job Seekers
    • For Employers
    • Jobs Board
  • Abstracts
    • Abstract FAQ
    • Submission Tips
    • Podium Presentation Guidelines
    • Poster Presentation Guidelines
    • Abstract Topic Categories
    • Major Symposium Guidance for Trainees
    • Abstract Policies and Procedures
    • Program Acknowledgements
  • Exhibitors
  • Sponsors
  • Resources
    • Attendee Social Media Toolkit
    • Presenter Social Media Toolkit
    • Podium Presentation Guidelines
    • Poster Presentation Guidelines
  • FAQ
    • General FAQ
    • Abstract FAQ
    • Registration FAQ
  • Show Search
Hide Search

Postdoctoral Fellow

Boston College
Chestnut Hill, Massachusetts, USA

We are currently seeking a highly motivated postdoctoral fellow for a translational research project that focuses on studying the role of viral insulins in the insulin/IGF-1 signaling system, growth, and cancer progression. The Altindis Lab at the Boston College Biology Department received its first NIH R01 grant and the postdoc will be supported with this mechanism.

We recently made a surprising discovery, demonstrating that viruses encode insulin/IGF-1-like sequences known as viral insulin/IGF-1-like peptides (VILPs). While most VILPs act as natural agonists of human receptors, our research has revealed that two VILPs function as natural antagonists of the IGF-1 receptor (IGF1R).

We are in search of a productive and independent postdoctoral researcher to join us in further characterizing viral insulins. The primary objective of this project is to elucidate the mechanism of action of VILPs that inhibit IGF1R. Our ultimate goal is to translate these findings into breast cancer and prostate cancer research. The position is available. Applications will be considered on a rolling basis until the positions are filled, offering a salary higher than the NIH scale ($65,000 starting from June 2024 for first-year postdocs), along with comprehensive employee benefits.

For more information, visit https://altindislab.com/open-positions/positions.

Posting ID: 392

« Postdoc Associate
Post-Doctoral Research Associate »
AAI Logo

Footer

IMMUNOLOGY2024™

May 3–7, 2024
McCormick Place
Chicago, Illinois, USA

Copyright © 2025 The American Association of Immunologists. All rights reserved.